STZ injection reduced significantly mRNA expression of SDF-1 (p < 0.01; Figure 8A), Ang1 (p < 0.05; Figure 8B), and β-catenin (p < 0.05; Figure 8C) in BM cells at 60 days post-hyperglycemia induction. The gene discussed is CXCL12; the disease is Hyperglycemia.